| Dr James M Douglas Jr, MD | |
|
2979 Squalicum Pkwy, Bellingham, WA 98225-1811 | |
| (360) 788-6800 | |
| (360) 788-6801 |
| Full Name | Dr James M Douglas Jr |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 46 Years |
| Location | 2979 Squalicum Pkwy, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588626071 | NPI | - | NPPES |
| 7545055 | Other | WA | AETNA |
| 35311 | Other | WA | REGENCE |
| 1588626071 | Medicaid | WA | |
| 139002 | Other | WA | L&I AND CRIME VICTIMS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | MD00032041 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bellingham, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peacehealth | 9537073960 | 259 |
News Archive
Results of two clinical trials reported at the American Society for Clinical Oncology Annual Meeting 2015 show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically in the context of PD1 signaling that some tumors use to avoid immune system attack. Dr. Rene Gonzalez, MD, investigator at the University of Colorado Cancer Center and director of the Melanoma Research Clinics at the CU School of Health, is an author of both studies.
Contrary to popular belief, the worst injuries baseball catchers face on the field come from errant bats and foul balls, not home-plate collisions with base runners, according to findings of a study led by researchers at the Johns Hopkins University School of Medicine.
Merck, known as MSD outside the United States and Canada, announced today that the company has signed two licensing agreements for investigational HIV drug candidates.
Canadian researchers have determined that community-based pharmacists could provide an added resource in identifying knee osteoarthritis (OA). The study, published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), represents the first evidence supporting a collaborative approach to managing knee OA.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
Results of two clinical trials reported at the American Society for Clinical Oncology Annual Meeting 2015 show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically in the context of PD1 signaling that some tumors use to avoid immune system attack. Dr. Rene Gonzalez, MD, investigator at the University of Colorado Cancer Center and director of the Melanoma Research Clinics at the CU School of Health, is an author of both studies.
Contrary to popular belief, the worst injuries baseball catchers face on the field come from errant bats and foul balls, not home-plate collisions with base runners, according to findings of a study led by researchers at the Johns Hopkins University School of Medicine.
Merck, known as MSD outside the United States and Canada, announced today that the company has signed two licensing agreements for investigational HIV drug candidates.
Canadian researchers have determined that community-based pharmacists could provide an added resource in identifying knee osteoarthritis (OA). The study, published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), represents the first evidence supporting a collaborative approach to managing knee OA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James M Douglas Jr, MD 2979 Squalicum Pkwy, Bellingham, WA 98225-1811 Ph: (360) 788-6800 | Dr James M Douglas Jr, MD 2979 Squalicum Pkwy, Bellingham, WA 98225-1811 Ph: (360) 788-6800 |
News Archive
Results of two clinical trials reported at the American Society for Clinical Oncology Annual Meeting 2015 show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically in the context of PD1 signaling that some tumors use to avoid immune system attack. Dr. Rene Gonzalez, MD, investigator at the University of Colorado Cancer Center and director of the Melanoma Research Clinics at the CU School of Health, is an author of both studies.
Contrary to popular belief, the worst injuries baseball catchers face on the field come from errant bats and foul balls, not home-plate collisions with base runners, according to findings of a study led by researchers at the Johns Hopkins University School of Medicine.
Merck, known as MSD outside the United States and Canada, announced today that the company has signed two licensing agreements for investigational HIV drug candidates.
Canadian researchers have determined that community-based pharmacists could provide an added resource in identifying knee osteoarthritis (OA). The study, published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), represents the first evidence supporting a collaborative approach to managing knee OA.
› Verified 6 days ago
Robert C Oram, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4280 Meridian St Ste 110, Bellingham, WA 98226 Phone: 360-788-7733 Fax: 360-676-7471 |